Filter  MonthJanFebMarAprMayJunJulAugSepOctNovDec Year20022003200420052006200720082009201020112012 5101520253050100All Filter

• Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints

  Created: Wednesday, December 12, 2007 04:00 PM Author: Tyler Reilly

  Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy EndpointsDate: December 13, 2007Genzyme Corp. (Nasdaq: GENZ) announced today that its Late Onset Treatment Study (LOTS) of Myozyme® (alglucosidase alfa) met its co-prim...

• Company develops drug treatments for rare diseases

  Created: Thursday, July 26, 2007 04:00 PM Author: Tyler Reilly

  White House honours GengzymeCompany develops drug treatments for rare diseases 8 The Mississauga News -Friday, July 27, 2007 Genzyme Canada is being honored today at the White House for helping to improve the health of people with rare diseases.U.S. ...

• Lisgar resident helps open door to new drug

  Created: Tuesday, February 27, 2007 04:00 PM Author: John Stewart

  Lisgar resident helps open door to new drugMississauga News Wednesday February 28 2007 Health Lisgar resident helps open door to new drug By John Stewartstaff For years, Guy Ashford-Smith wondered what was wrong with him because he seemed to catch pn...